Viewing nowMyungmun Atorvastatin Tablet 10 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Myungmun Pharm Co., Ltd.

MFDS item code 201307887 · Approved 2013.06.27 · Insurance code 649806290
Improves hyperlipidemia; prevents cardiovascular diseases (such as myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. In particular, it lowers the risks of myocardial infarction, stroke, complications after vascular procedures, and angina in adult patients with risk factors for coronary heart disease or type 2 diabetes. Additionally, it prevents non-fatal myocardial infarction and strokes in patients who already have coronary heart disease, and reduces hospitalizations due to congestive heart failure. This drug is also effective in treating hyperlipidemia, lowering total cholesterol, LDL cholesterol, and triglyceride levels while raising good cholesterol (HDL) levels. It is particularly useful for patients with familial or mixed dyslipidemia who do not respond adequately to dietary interventions. In children with hypercholesterolemia that is not controlled, it may also be used to improve blood lipid levels. This medication is used to improve cardiovascular health and reduce disease risks.
Patients receiving atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. This medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg only when a reduction in LDL cholesterol of 45 % or more is required). This medication is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medication is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.
2. Pediatric patients (10 ~ 17 years) with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses higher than 20 mg of this medication in pediatric patients.). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This drug may cause muscle abnormalities, so if there is severe muscle pain or weakness, or a significant increase in creatine kinase levels, treatment should be discontinued immediately. Particularly, patients at risk of impaired kidney function due to serious infections or surgeries are advised to temporarily halt the use of this medication. This drug should not be used in patients with certain allergic reactions or liver disease, muscle disorders, in pregnant or breastfeeding women, or in children under 10 years old. Patients with a history of alcohol dependence or liver disease, impaired kidney function, hypothyroidism, or the elderly should take this medication with caution. This medication can affect liver function, so regular liver function tests are necessary before and during treatment. Women of childbearing age must use effective contraception while taking this drug, and should discontinue it immediately if pregnancy is confirmed. This medication can interact with several other drugs, so it's essential to inform your doctor or pharmacist about any other medications being taken. Caution is especially required when taken with certain antibiotics, antifungals, antivirals, some antihypertensives, and oral contraceptives. There is no specific antidote for overdose, so treatment should be based on symptoms, and liver function and muscle-related tests should be performed. Keep this medication out of the reach of children, and store it in its original container to prevent misuse or deterioration. If symptoms such as muscle pain, fatigue, or fever occur during treatment, notify healthcare personnel immediately and undergo evaluation. This drug has been rarely reported to cause serious muscle abnormalities, liver dysfunction, or allergic reactions in some patients in clinical trials and post-marketing studies, so caution is warranted.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a longer time.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Myungmun Pharm Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.